Abstract
Background and Aims : The aim of the study was to evaluate the therapy effectiveness by β-blockers bisoprolol or nebivolol in combination with eplerenone on myocardial fibrosis markers in patients with heart failure with mid-range ejection fraction (HFmrEF) and metabolic disorders.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
